Psychedelics are emerging as promising therapies in the treatment of various neurological and psychiatric conditions. Though psychedelics are controlled substances in most countries, clinical trials exploring the use of psychedelics are underway. Psychedelics have potential in the treatment of numerous conditions, including major depressive disorder, anxiety, post-traumatic stress disorder (PTSD), substance use disorder, cluster headaches, as well as psychological distress associated with end of life.